Lead Product(s) : Zosurabalpin
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Roche Moves Antibiotic Against Superbug into Phase 3 of Testing
Details : RO7223280 (zosurabalpin) is an antobiotic which is being evaluated for the treatment of acinetobacter infections.
Product Name : RO7223280
Product Type : Antibiotic
Upfront Cash : Inapplicable
May 26, 2025
Lead Product(s) : Zosurabalpin
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
